Autoimmune Disease Treatment Companies

ID: MRFR/Pharma/4137-HCR

200 Pages

Vikita Thakur

Last Updated: February 16, 2025

Acute care electronic health record (EHR) companies specialize in providing electronic health record systems specifically tailored for acute care settings such as hospitals, emergency departments, and urgent care facilities. These EHR systems are designed to support the unique needs of fast-paced, high-acuity environments where timely and accurate patient information is crucial

Autoimmune Disease Treatment Market

Market Size

Forecast Period2025 - 2035

CAGR (2025 - 2035)7.01%

2024 Market Size$ 18.23 Billion

2025 Market Size$ 19.51 Billion

2035 Market Size$ 38.42 Billion

Key Players

Companies such as AbbVie

Roche

Johnson & Johnson

 Amgen

Bristol-Myers Squibb

Gilead Sciences

Trends

Personalized Medicine
Biologics and Targeted Therapies
Increased Research and Development

Opportunities

Rising Prevalence of Autoimmune Diseases
Advancements in Biologics and Targeted Therapies
Increased Investment in Research and Development

Summary Table of Contents Segmentation Download PDF

Top Industry Leaders in the Autoimmune Disease Treatment Market

Autoimmune Disease Treatment Key Companies

Latest Autoimmune Disease Treatment Companies Update

Immunovant (IMVT) Soared nearly 100% after Phase 1 trial results of their injectable treatment, IMVT-1402, showed successful reduction in disease-causing antibodies. Phase 2 trials are planned for 2024.

AstraZeneca Announced positive Phase 3 data for their anti-IL-17A drug, brodalumab, showing significant improvement in psoriatic arthritis symptoms compared to placebo. Regulatory submissions are planned for 2024.

Eli Lilly Reported positive Phase 2b data for their JAK inhibitor, abrocitinib, in treating ulcerative colitis. They plan to initiate Phase 3 trials in 2024.

Pfizer Acquired Viavi Pharmaceuticals for $5.2 billion, gaining access to Viavi's late-stage lupus drug, atacicept. This strengthens Pfizer's autoimmune disease portfolio.

Roche and Gilead Formed a research collaboration to develop new treatments for inflammatory bowel disease. This combines expertise and resources to accelerate discoveries.

Sanofi and Kymab Partnered to develop and commercialize anti-inflammatory antibodies targeting IL-17C and IL-17A for various autoimmune diseases.

List of Autoimmune Disease Treatment Key Companies in the Market

• Abbott Laboratories

• Amgen Inc.

• Genentech Inc.

• Bayer Schering Pharma AG

• Biogen Idec Inc.

• Bio-Rad

• Chugai Pharmaceutical Co. Ltd.

• Danaher

• Elan Corporation Plc

• Eli Lilly and Company

• F. Hoffmann-La Roche AG

• GlaxoSmithKline Plc

• HYCOR Biomedical

• Johnson & Johnson Inc.

• Merck & Co. Inc.

Customize Report

Certified Researchers

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”